Exploring IPI's Global Network

Exploring IPI's Global Network

At IPI, we pioneer pharmaceutical and healthcare advancements globally through strategic partnerships, uniting expertise to develop cutting-edge solutions, enhance patient care, and tackle diverse healthcare challenges.
Global Engagement

Global Engagement

During our attendance at the World Pharmaceutical Components Conference (#IPIpharma) in Barcelona, Spain, we proudly presented our Iraqi-produced medicines (#CPhI). We also engaged in a wide range of discussions, covering topics from the next generation of biomanufacturing to innovations in sustainable solutions within the pharmaceutical sector.
Basra Summit: Fostering Progress in Blood Disease Treatment

Basra Summit: Fostering Progress in Blood Disease Treatment

The Iraqi Blood Diseases Summit in Basra brought together leading experts and doctors to collaborate on advancing the field. It aimed to drive progress in research, diagnosis, and treatment methods for blood disorders, ultimately improving healthcare outcomes.
Launching Conference of IPI Pharma Company

Launching Conference of IPI Pharma Company

The launching conference of the Iraqi Pharmaceutical Industry Company showcased a 90% attendance rate among healthcare providers, underscoring our dedication to delivering high-quality oncology and hematology medications. This event culminated in a strategic partnership aimed at advancing healthcare standards in Iraq.
IPI Leads Nation in Local Cancer Drug Production

IPI Leads Nation in Local Cancer Drug Production

Iraq's pharmaceutical industry has achieved a significant milestone by locally producing cancer drugs for the first time. Under the guidance of Minister of Health Dr. Saleh Al-Hasnawi, the Ministry has partnered with Iraqi factories to improve medicine production. The Iraq Pharmaceutical Industry (IPI), established in 1954, meets European standards and has notably reduced costs. This accomplishment brings Iraq one step closer to pharmaceutical self-sufficiency, guaranteeing quality healthcare for its citizens.
The Evolution of IPI

The Evolution of IPI

IPI was established in 1954, underwent a significant transformation in 2012 with a $20 million investment to meet global standards. Achieving multiple quality certifications, the factory became a regional leader, producing 12 million capsules monthly. Sales surged from 20 to 70 billion Iraqi dinars by 2022, solidifying Iraq's position as a regional pharmaceutical powerhouse, with plans for continued expansion and exportation.